A Pharmacokinetic and Safety Study of MY008211A Tablets in Subjects With Impaired or Normal Hepatic Function

NCT07625618 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Insufficiency (MeSH ID: D048550)

Interventions

DRUG: MY008211A tablets

Sponsor

Wuhan Createrna Science and Technology Co., Ltd